Key Insights

Highlights

Treatment Research

3 treatments under study, led by Fosmanogepix

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07881224Phase 1Recruiting

A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult Subjects

Showing all 1 trials

Research Network

Common Treatments

  • Fosmanogepix1
  • Probe Substrates Repaglinide Rosuvastatin And Digoxin1
  • The Medicine Cocktail Caffeine Bupropion Flurbiprofen Omeprazole Dextromethorphan And Midazolam1

Active Sponsors

  • Basilea Pharmaceutica International AG Allschwil1
  • Basilea Pharmaceutica1
  • Biomedical Advanced Research and Development Authority1

Top Investigators

Related Conditions

  • Healthy Adult Participants1

Activity Timeline